Technology & Science
2026 Nobel Medicine Prize Honors Inventors of Optogenetic Light Switch for Neurons
On 5 Oct 2026, Stockholm’s Karolinska Institute awarded the Nobel Prize in Physiology or Medicine to Karl Deisseroth, Peter Hegemann and Georg Nagel for turning an algae light-sensing protein into a genetic switch that can start or stop single neurons with flashes of blue light.
Focusing Facts
- Laureates share 12 million SEK (≈US$1.2 m) for their discoveries on light-gated ion channels, announced at 11:30 CEST on 5 Oct 2026.
- Deisseroth first activated channelrhodopsin-engineered mouse neurons in vivo in 2005 via a 200-µm optical fibre, proving millisecond-precision control.
- Optogenetic gene therapy entered Phase I/II trials for retinitis pigmentosa in 2021, giving legally blind patients partial light perception.
See how 3 sources reported this story.
- ✓ Full multi-perspective analysis on every story
- ✓ Primary source links for every claim
- ✓ Daily email briefing — no algorithm
Perspectives in this article
- Academic commentary outlets
- Mainstream U.S. news outlets
- Institutional and local celebration pieces